Circulating AMH reflects ovarian morphology by magnetic resonance imaging and 3D ultrasound in 121 healthy girls

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 3, 2015, Pages 880-890

  Hagen, Casper P ^a   Mouritsen, Annette ^a   Mieritz, Mikkel G ^a   Tinggaard, Jeanette ^a   Wohlfart Veje, Christine ^a   Fallentin, Eva ^a   Brocks, Vibeke ^a   Sundberg, Karin ^a   Jensen, Lisa Neerup ^a   Anderson, Richard A ^b   Juul, Anders ^a   Main, Katharina M ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; ESTRADIOL; FOLLITROPIN; INHIBIN B; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR;

ADOLESCENT; ARTICLE; BODY MASS; CHILD; CLINICAL EXAMINATION; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; FEMALE GENITAL TRACT PARAMETERS; GIRL; GYNECOLOGICAL EXAMINATION; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MENARCHE; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARIAN VOLUME; OVARY; OVARY FOLLICLE; OVARY POLYCYSTIC DISEASE; PHYSICAL DEVELOPMENT; PREPUBERTY; PRIORITY JOURNAL; SCHOOL CHILD; THREE DIMENSIONAL ECHOCARDIOGRAPHY; ANATOMY AND HISTOLOGY; BLOOD; CYTOLOGY; ECHOGRAPHY; HEALTH; ORGAN SIZE; PROCEDURES; THREE DIMENSIONAL IMAGING;

ADOLESCENT; ANTI-MULLERIAN HORMONE; CHILD; COHORT STUDIES; FEMALE; HEALTH; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; ORGAN SIZE; OVARIAN FOLLICLE; OVARY; ULTRASONOGRAPHY;

EID: 84924955690     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-3336     Document Type: Article

References (40)

1. Dewailly D, Gronier H, Poncelet E, et al. Diagnosis of polycystic ovary syndrome (PCOS): Revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Hum Reprod. 2011;26:3123-3129.
2. Brown M, Park AS, Shayya RF, Wolfson T, Su HI, Chang RJ. Ovarian imaging by magnetic resonance in adolescent girls with polycystic ovary syndrome and age-matched controls. J Magn Reson Imaging. 2013;38:689-693.
3. Kelsey TW, Dodwell SK, Wilkinson AG, et al. Ovarian volume throughout life: A validated normative model. PLoS One. 2013;8:e71465.
4. Lintern-Moore S, Peters H, Moore GP, Faber M. Follicular development in the infant human ovary. J Reprod Fertil. 1974;39:53-64.
5. Peters H, Byskov AG, Grinsted J. Follicular growth in fetal and prepubertal ovaries of humans and other primates. Clin Endocrinol Metab. 1978;7:469-485.
6. Ersen A, Onal H, Yildirim D, Adal E. Ovarian and uterine ultrasonography and relation to puberty in healthy girls between 6 and 16 years in the Turkish population: A cross-sectional study. J Pediatr Endocrinol Metab. 2012;25:447-451.
7. Holm K, Laursen EM, Brocks V, Müller J. Pubertal maturation of the internal genitalia: An ultrasound evaluation of 166 healthy girls. Ultrasound Obstet Gynecol. 1995;6:175-181.
8. Jeppesen JV, Anderson RA, Kelsey TW, et al. Which follicles make the most anti-Mullerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection. Mol Hum Reprod. 2013;19(8):519-527.
9. Pellatt L, Rice S, Dilaver N, et al. Anti-Müllerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells. Fertil Steril. 2011;96:1246-1251.e1.
10. Andersen CY, Lossl K. Increased intrafollicular androgen levels affect human granulosa cell secretion of anti-Müllerian hormone and inhibin-B. Fertil Steril. 2008;89:1760-1765.
11. Grynberg M, Pierre A, Rey R, et al. Differential regulation of ovarian anti-müllerian hormone (AMH) by estradiol through α- and β-estrogen receptors. J Clin Endocrinol Metab. 2012;97:E1649-E1657.
12. Stubbs SA, Hardy K, Da Silva-Buttkus P, et al. Anti-Müllerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries. J Clin Endocrinol Metab. 2005;90:5536-5543.
13. de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. Anti-müllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril. 2002;77:357-362.
14. Hansen KR, Hodnett GM, Knowlton N, Craig LB. Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertil Steril. 2011;95:170-175.
15. Tehrani FR, Solaymani-Dodaran M, Tohidi M, Gohari MR, Azizi F. Modeling Age at Menopause Using Serum Concentration of Anti-Mullerian Hormone. J Clin Endocrinol Metab. 2013;98(2):729-735.
16. Dewailly D, Andersen CY, Balen A, et al. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update 2014;20:370-385.
17. Hagen CP, Aksglaede L, Sørensen K, et al. Serum levels of anti-Müllerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients. J Clin Endocrinol Metab. 2010;95:5003-5010.
18. Hagen CP, Aksglaede L, Sørensen K, et al. Individual serum levels of anti-Müllerian hormone in healthy girls persist through childhood and adolescence: A longitudinal cohort study. Hum Reprod. 2012;27:861-866.
19. Visser JA, Hokken-Koelega AC, Zandwijken GR, Limacher A, Ranke MB, Flück CE. Anti-Müllerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatment. Hum Reprod. 2013;28:1899-1907.
20. Hagen CP, Sørensen K, Anderson RA, Juul A. Serum levels of antimüllerian hormone in early maturing girls before, during, and after suppression with GnRH agonist. Fertil Steril. 2012;98:1326-1330.
21. Badik JR, Castañeda U, Gleason TJ, et al. Ovarian function in Duarte galactosemia. Fertil Steril. 2011;96:469-473.e1.
22. Brougham MF, Crofton PM, Johnson EJ, Evans N, Anderson RA, Wallace WH. Anti-Müllerian hormone is a marker of gonadotoxicity in pre- and postpubertal girls treated for cancer: A prospective study. J Clin Endocrinol Metab. 2012;97:2059-2067.
23. Lie Fong S, Laven JS, Hakvoort-Cammel FG, et al. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone. Hum Reprod. 2009;24:982-990.
24. Baker TG. a quantitative and cytological study of germ cells in human ovaries. Proc R Soc Lond B Biol Sci. 1963;158:417-433.
25. Lashen H, Dunger DB, Ness A, Ong KK. Peripubertal changes in circulating antimüllerian hormone levels in girls. Fertil Steril. 2013;99:2071-2075.
26. Kelsey TW, Anderson RA, Wright P, Nelson SM, Wallace WH. Data-driven assessment of the human ovarian reserve. Mol Hum Reprod. 2012;18:79-87.
27. Boisen KA, Kaleva M, Main KM, et al. Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet. 2004;363:1264-1269.
28. Chellakooty M, Schmidt IM, Haavisto AM, et al. Inhibin A, Inhibin B, follicle-stimulating hormone, luteinizing hormone, estradiol, and sex hormone-binding globulin levels in 473 healthy infant girls. J Clin Endocrinol Metab. 2003;88:3515-3520.
29. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969;44:291-303.
30. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41-47.
31. Søeborg T, Frederiksen H, Fruekilde P, Johannsen TH, Juul A, Andersson AM. Serum concentrations of DHEA, DHEAS, 17α-hydroxyprogesterone, Δ4-androstenedione and testosterone in children determined by TurboFlow-LC-MS/MS. Clin Chim Acta. 2013;419:95-101.
32. Leonhardt H, Hellström M, Gull B, et al. Ovarian morphology assessed by magnetic resonance imaging in women with and without polycystic ovary syndrome and associations with antimüllerian hormone, free testosterone, and glucose disposal rate. Fertil Steril. 2014;101:1747-1756.
33. Chai J, Howie AF, Cameron DA, Anderson RA. A highly-sensitive anti-Müllerian hormone assay improves analysis of ovarian function following chemotherapy for early breast cancer. Eur J Cancer. 2014;50:2367-2374.
34. Wellons MF, Bates GW, Schreiner PJ, Siscovick DS, Sternfeld B, Lewis CE. Antral follicle count predicts natural menopause in a population-based sample: The Coronary Artery Risk Development in Young Adults Women's Study. Menopause. 2013;20:825-830.
35. Hagen CP, Aksglaede L, Sørensen K, et al. FSHB-211 and FSHR 2039 are associated with serum levels of follicle-stimulating hormone and antimüllerian hormone in healthy girls: a longitudinal cohort study. Fertil Steril. 2013;100:1089-1095.
36. Wallace WH, Kelsey TW. Human ovarian reserve from conception to the menopause. PLoS One. 2010;5:e8772.
37. Gougeon A. Ovarian follicular growth in humans: Ovarian ageing and population of growing follicles. Maturitas. 1998;30:137-142.
38. Leonhardt H, Gull B, Stener-Victorin E, Hellström M. Ovarian volume and antral follicle count assessed by MRI and transvaginal ultrasonography: A methodological study. Acta Radiol. 2014;55:248-256.
39. Hart R, Doherty DA, Norman RJ, et al. Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS). Fertil Steril. 2010;94:1118-1121.
40. Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet. 2007;370:685-697.